Abnormal levels of expression of plasma MicroRNA-33 in patients with psoriasis;Alteraciones en los niveles de expresión del microARN-33 en plasma de pacientes con psoriasis

Actas Dermo-Sifiliograficas

Volumn 105, Issue 5, 2014, Pages 497-503

  Garcia Rodriguez S ^a   Arias Santiago, S ^b,c   Orgaz Molina, J ^b   Magro Checa, C ^b   Valenzuela, I ^c   Navarro, P ^a   Naranjo Sintes, R ^b   Sancho, J ^a   Zubiaur, M ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Carotid intima media thickness; Insulin; miRNA 126; miRNA 33; Psoriasis

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 33; UNCLASSIFIED DRUG; MIRN126 MICRORNA, HUMAN; MIRN33 MICRORNA, HUMAN;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMATOSIS; BODY SURFACE; CARDIOVASCULAR RISK; CAROTID ATHEROMATOSIS; CLINICAL ARTICLE; EXPLORATORY RESEARCH; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; REAL TIME POLYMERASE CHAIN REACTION; ADULT; BLOOD; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; PSORIASIS;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; PSORIASIS;

EID: 84901661096     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2014.04.003     Document Type: Article

References (30)

1. F.O. Nestle, D.H. Kaplan, and J. Barker Psoriasis N Engl J Med 361 2009 496 509
2. S. Garcia-Rodriguez, S. Arias-Santiago, R. Perandrés-López, L. Castellote, E. Zumaquero, and P. Navarro et al. Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis J Eur Acad Dermatol Venereol 27 2013 242 250
3. E.D. Roberson, and A.M. Bowcock Psoriasis genetics: Breaking the barrier Trends Genet 26 2010 415 423
4. X. Zhou, J.G. Krueger, M.C. Kao, E. Lee, F. Du, and A. Menter et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array Physiol Genomics 13 2003 69 78
5. E. Sonkoly, T. Wei, P.C. Janson, A. Saaf, L. Lundeberg, and M. Tengvall-Linder et al. MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2 2007 e610
6. N. Xu, P. Brodin, T. Wei, F. Meisgen, L. Eidsmo, and N. Nagy et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2 J Invest Dermatol 131 2011 1521 1529
7. F. Meisgen, N. Xu, T. Wei, P.C. Janson, S. Obad, and O. Broom et al. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis Exp Dermatol 21 2012 312 314
8. D. Baek, J. Villen, C. Shin, F.D. Camargo, S.P. Gygi, and D.P. Bartel The impact of microRNAs on protein output Nature 455 2008 64 71
9. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
10. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, and E.L. Pogosova-Agadjanyan et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
11. A. Zampetaki, P. Willeit, I. Drozdov, S. Kiechl, and M. Mayr Profiling of circulating microRNAs: From single biomarkers to re-wired networks Cardiovasc Res 93 2012 555 562
12. K.C. Vickers, B.T. Palmisano, B.M. Shoucri, R.D. Shamburek, and A.T. Remaley MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat Cell Biol 13 2011 423 433
13. S. Zhang, L. Chen, E.J. Jung, and G.A. Calin Targeting microRNAs with small molecules: From dream to reality Clin Pharmacol Ther 87 2010 754 758
14. N. Shen, D. Liang, Y. Tang, N. de Vries, and P.P. Tak MicroRNAs - novel regulators of systemic lupus erythematosus pathogenesis Nat Rev Rheumatol 8 2012 701 709
15. I. Duroux-Richard, C. Jorgensen, and F. Apparailly What do microRNAs mean for rheumatoid arthritis Arthritis Rheum 64 2012 11 20
16. S. Koba, M. Jinnin, K. Inoue, W. Nakayama, N. Honda, and K. Makino et al. Expression analysis of multiple microRNAs in each patient with scleroderma Exp Dermatol 22 2013 489 491
17. A. Pivarcsi, F. Meisgen, N. Xu, M. Ståhle, and E. Sonkoly Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy Br J Dermatol 169 2013 563 570
18. A. Davalos, and C. Fernandez-Hernando From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport Pharmacol Res 75 2013 60 72
19. K.J. Rayner, Y. Suarez, A. Davalos, S. Parathath, M.L. Fitzgerald, and N. Tamehiro et al. MiR-33 contributes to the regulation of cholesterol homeostasis Science 328 2010 1570 1573
20. S. Fichtlscherer, A.M. Zeiher, and S. Dimmeler Circulating microRNAs biomarkers or mediators of cardiovascular diseases Arterioscler Thromb Vasc Biol 31 2011 2383 2390
21. S. Wang, A.B. Aurora, B.A. Johnson, X. Qi, J. McAnally, and J.A. Hill et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis Dev Cell 15 2008 261 271
22. A.M. Tobin, D.J. Veale, O. Fitzgerald, S. Rogers, P. Collins, and D. O'Shea et al. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis J Rheumatol 37 2010 1386 1394
23. S. Arias-Santiago, J. Orgaz-Molina, L. Castellote-Caballero, M.A. Arrabal-Polo, S. Garcia-Rodriguez, and R. Perandres-Lopez et al. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis Eur J Dermatol 22 2012 337 344
24. H.M. Kremers, M.T. McEvoy, F.J. Dann, and S.E. Gabriel Heart disease in psoriasis J Am Acad Dermatol 57 2007 347 354
25. A.B. Gottlieb, F. Dann, and A. Menter Psoriasis and the metabolic syndrome J Drugs Dermatol 7 2008 563 572
26. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) method Methods 25 2001 402 408
27. N. Rotllan, and C. Fernandez-Hernando MicroRNA regulation of cholesterol metabolism Cholesterol 2012 2012 847849
28. T. Horie, O. Baba, Y. Kuwabara, Y. Chujo, S. Watanabe, and M. Kinoshita et al. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice J Am Heart Assoc 1 2012 e003376
29. Adam L, Wszolek MF, Liu C-G, Jing W, Diao L, Zien A, et al. Plasma microRNA profiles for bladder cancer detection. Urologic Oncology: Seminars and Original Investigations; 2013;31:1701-8.
30. P. Mocharla, S. Briand, G. Giannotti, C. Dörries, P. Jakob, and F. Paneni et al. AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: Role for proangiogenic effects and alterations in type 2 diabetics Blood 121 2013 226 236